The Zed Files[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]
Articles
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$ETRM - EnteroMedics (ETRM) Announces 3-Year Data from vBloc Diabetic Patient Study Published in Journal of Diabetes and...
$ZFGN: No one is bringing up the fact that in addition to JMP's and others investments firms giving it an Outperform, pe...